George A Fisher (George Fisher)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Small Cell Lung Cancer

Systemic Lupus Erythematosus

Neuroendocrine Tumors

Tyrosine Kinase

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of surgical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel A King, Amber R Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S Peter Goedegebuure, Sheeno Thyparambil, Wei-Li Liao, Aaron McCormick, Jihang Ju, Michele Cioffi, Xiuli Zhang, Jasreet Hundal, Malachi Griffith, Carla Grandori, Maddy Pollastro, Rachele Rosati, Astrid Margossian, Payel Chatterjee, Trevor Ainge, Marta Flory, Paolo Ocampo, Lee-May Chen, George A Poultsides, Ari D Baron, Daniel T Chang, Joseph M Herman, William E Gillanders, Haeseong Park, William A Hoos, Mike Nichols, George A Fisher, Calvin J Kuo
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO precision oncology 7 (2023)
Daniel A King, Julianna J Weiel, Rochelle Reyes, Meredith A Mills, Antonita Itchon, George A Fisher, James M Ford, Carlos J Suarez
Therapeutic Implications of Oncogenic Missense HER2 ( ERBB2 ) Mutations in Gastric Adenocarcinoma. JCO precision oncology 7 (2023)
Daniel A King, Julianna J Weiel, Rochelle Reyes, Meredith A Mills, Antonita Itchon, George A Fisher, James M Ford, Carlos J Suarez
Therapeutic Implications of Oncogenic Missense HER2 ( ERBB2 ) Mutations in Gastric Adenocarcinoma. JCO precision oncology 7 (2023)
Daniel A King, Amber R Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S Peter Goedegebuure, Sheeno Thyparambil, Wei-Li Liao, Aaron McCormick, Jihang Ju, Michele Cioffi, Xiuli Zhang, Jasreet Hundal, Malachi Griffith, Carla Grandori, Maddy Pollastro, Rachele Rosati, Astrid Margossian, Payel Chatterjee, Trevor Ainge, Marta Flory, Paolo Ocampo, Lee-May Chen, George A Poultsides, Ari D Baron, Daniel T Chang, Joseph M Herman, William E Gillanders, Haeseong Park, William A Hoos, Mike Nichols, George A Fisher, Calvin J Kuo
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO precision oncology 7 (2023)
Daniel A King, Amber R Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S Peter Goedegebuure, Sheeno Thyparambil, Wei-Li Liao, Aaron McCormick, Jihang Ju, Michele Cioffi, Xiuli Zhang, Jasreet Hundal, Malachi Griffith, Carla Grandori, Maddy Pollastro, Rachele Rosati, Astrid Margossian, Payel Chatterjee, Trevor Ainge, Marta Flory, Paolo Ocampo, Lee-May Chen, George A Poultsides, Ari D Baron, Daniel T Chang, Joseph M Herman, William E Gillanders, Haeseong Park, William A Hoos, Mike Nichols, George A Fisher, Calvin J Kuo
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO precision oncology 7 (2023)
Daniel A King, Amber R Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S Peter Goedegebuure, Sheeno Thyparambil, Wei-Li Liao, Aaron McCormick, Jihang Ju, Michele Cioffi, Xiuli Zhang, Jasreet Hundal, Malachi Griffith, Carla Grandori, Maddy Pollastro, Rachele Rosati, Astrid Margossian, Payel Chatterjee, Trevor Ainge, Marta Flory, Paolo Ocampo, Lee-May Chen, George A Poultsides, Ari D Baron, Daniel T Chang, Joseph M Herman, William E Gillanders, Haeseong Park, William A Hoos, Mike Nichols, George A Fisher, Calvin J Kuo
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO precision oncology 7 (2023)
Daniel A King, Amber R Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S Peter Goedegebuure, Sheeno Thyparambil, Wei-Li Liao, Aaron McCormick, Jihang Ju, Michele Cioffi, Xiuli Zhang, Jasreet Hundal, Malachi Griffith, Carla Grandori, Maddy Pollastro, Rachele Rosati, Astrid Margossian, Payel Chatterjee, Trevor Ainge, Marta Flory, Paolo Ocampo, Lee-May Chen, George A Poultsides, Ari D Baron, Daniel T Chang, Joseph M Herman, William E Gillanders, Haeseong Park, William A Hoos, Mike Nichols, George A Fisher, Calvin J Kuo
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO precision oncology 7 (2023)
Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher, Teri A Longacre, Carlos J Suarez, Brock A Martin, James C Yao, Matthew H Kulke, Andrew E Hendifar, James C Shanks, Manisha H Shah, Mark M Zalupski, Edmond L Schmulbach, Diane L Reidy, Jonathan R Strosberg, Peter J O'Dwyer, Al Bowen Benson
A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
George A Fisher, Peter O'Dwyer
Importance of surgeons in cooperative groups: Perspectives from the medical oncologists. Journal of surgical oncology 125 (1) (2021)
Takahiro Tsujikawa, Todd Crocenzi, Jennifer N Durham, Elizabeth A Sugar, Annie A Wu, Beth Onners, Julie M Nauroth, Robert A Anders, Elana J Fertig, Daniel A Laheru, Kim Reiss, Robert H Vonderheide, Andrew H Ko, Margaret A Tempero, George A Fisher, Michael Considine, Ludmila V Danilova, Dirk G Brockstedt, Lisa M Coussens, Elizabeth D Thompson, Dung T Le
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)